Applied UV
Receives Order from Tennessee Department of Corrections for its
Scientific Air S-400 Patented
24/7 Large
Air Volume, Whole Room UV-C Pathogen
Killing Technology
Order represents entry into a significant new market vertical
(prisons and correctional facilities) for the company's pathogen
killing technology
Mount Vernon, NY
-- January 31, 2021 -- InvestorsHub NewsWire
-- Applied
UV, Inc. (NasdaqCM:
AUVI) ("Applied UV" or the
"Company"), a pathogen elimination technology company that applies
the power of narrow-range ultraviolet light ("UVC") for surface
areas and catalytic bioconversion technology for air purification
to destroy pathogens safely, thoroughly, and automatically,
announces it has
received a significant initial order from the Tennessee Department
of Correction ("TDOC") for its Scientific Air S-400
patented
24/7 large air
volume, whole room UV-C pathogen
killing technology for use in its Prison and Correctional
Facilities protecting incarcerated individuals and staff from
COVID-19 and other pathogens. The Scientific Air technology
is currently deployed and supports patients, staff and visitors in
large medical facilities and hospitals across the country as they
address the growing need for effective and safe airborne Infection
prevention. With this order, Applied UV is making its entry into
the prison and correctional facilities vertical, a large and
significant new market.
TDOC is a
Cabinet-level agency within the Tennessee state government manages
and operates 10 adult
prisons, contracts with a private prison management company for the
operation of one prison, and contracts with several counties for
the operation of
three other
prisons, collectively housing some
21,000 offenders.
Incarcerated
people are infected by the coronavirus at a rate more than five
times higher than the nation's
overall rate, according to research reported in the Journal of the
American Medical Association in July 2020. The reported death
rate of inmates (39 deaths per 100,000) is also higher than the
national rate (29 deaths per 100,000).
A significant and increasing percentage of the US population works
or resides in correctional facilities. The prevalence of infectious
diseases among incoming inmates is substantial, and the conditions
that exist within jails and prisons contribute to the further
amplification of contagious illnesses. Jails and prisons represent
unique and challenging environments in which to implement effective
infection-control strategies. In addition to immunization programs
and other preventive measures, deploying
portable air filter systems like the Scientific Air S-400
can
provide a solution to the unique challenges posed by the spread of
SARS-CoV-2 and other respiratory infections in prison settings and
create a cleaner, safer environment for inmates, staff and
visitors.
"We are very pleased to announce
this significant initial order from TDOC for the S-400
," said Max Munn,
Founder, Interim CEO and President of Applied UV. "Our work with
hundreds of large healthcare facilities across the country, where
pathogen spread is an ever-present challenge, has demonstrated the
clear and effective performance of the pathogen destruction
capabilities of our air purification technology.
Prisons
represent a significant challenge and opportunity, and we believe
our mobile S-400 whole-room disinfection system is the ideal
solution for most correctional facilities.
We look
forward to installing the systems at TDOC and vigorously pursuing
new opportunities with local, state and federal correctional
facilities to help reduce the spread
of SARS-CoV-2 and other respiratory infections."
Scientific
Air-S400 Operating Overview
-
Laboratory validated 99.99%+ kill
rate on viruses, bacteria, mold, odors and VOCS
-
No harmful
by-products
-
Rapid, portable, whole-room
disinfection via patented 3-phase design (HEPA, UV-C,
Carbon)
-
Safe and fast acting in occupied
spaces
-
Proven and tested in facilities
with EPA and FDA guideline compliance and trusted by Infection
Prevention, Facilities, EHS and EVS professionals
Scientific
Air Product Portfolio
Developed for healthcare
facilities, Scientific Air
is helping large facilities and hospitals across the country
address the growing need for effective and safe airborne Infection
prevention. Since 2015 Scientific Air and its predecessors have
been making air safer 24/7 in occupied spaces at facilities like:
NYU Medical
Center
University of
Rochester Medical Center
The Federal
VA Hospital System
Baptist
Health South
Kaiser
Permanente Medical of California
New York
Health + Hospital Corp.
Utilizing
Scientific Air systems, large facilities from government to
healthcare report significant reductions in viable airborne
pathogens as well as significant declines in non-viable
particulates including elimination of odor and VOC's. To view
third-party disinfection claims of the S400, please click on the
following link:
https://scientificairmanagement.com/evidence/
To view a video
of our powerful patented UV-C technology and how it disinfects
large volumes of fast-moving air by killing microscopic germs with
as much as a verified 99.9995% efficacy rating, please click on the
following link:
https://vimeo.com/521965332.
For more
information about Scientific Air, please visit:
https://scientificairmanagement.com/
About Applied
UV
Applied UV is focused on the
development and acquisition of technology that
address infection control in the healthcare, hospitality, commercial and
municipal markets. The Company has two wholly owned subsidiaries -
SteriLumen, Inc. ("SteriLumen") and Munn Works, LLC ("Munn
Works"). SteriLumen's connected
platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC)
to destroy pathogens safely, thoroughly, and automatically,
addressing the challenge of healthcare-acquired infections
("HAIs"). Targeted for use in facilities
that have high customer turnover such as hospitals, hotels,
commercial facilities, and other public spaces, the Company's
Lumicide™ platform uses UVC LEDs in several patented designs for
infection control in and around high-traffic areas, including sinks
and restrooms, killing bacteria, viruses, and other pathogens
residing on hard surfaces within devices' proximity. The Company's
patented in-drain disinfection device, Lumicide Drain, is the only
product on the market that addresses this critical pathogen
intensive location. SteriLumen's Airocide® air purification devices
are research backed, clinically proven and developed for NASA with
assistance from the University of Wisconsin. Airocide® is listed as an FDA
Class II Medical device, utilizes a proprietary photocatalytic
(PCO) bioconversion technology that draws air into a reaction
chamber that converts damaging molds, microorganisms, dangerous
airborne pathogens, destructive VOCs, allergens, odors and
biological gasses into harmless water vapor and green carbon
dioxide without producing ozone or other harmful
byproducts. Airocide®
applications include healthcare, hospitality, grocery chains, wine
making facilities, commercial real estate, schools, dental offices,
post-harvest, grocery, cannabis facilities and
homes.
For more information about
Applied UV, Inc., and its subsidiaries, please visit the following
websites:
https://www.applieduvinc.com/;
https://sterilumen.com/;
https://www.airocide.com
https://kesscience.com;
https://scientificairmanagement.com and,
https://munnworks.com/.
Forward-Looking
Statements
The information
contained herein may contain "forward-looking statements."
Forward-looking statements reflect the current view about future
events. When used in this press release, the words "anticipate,"
"believe," "estimate," "expect," "future," "intend," "plan," or the
negative of these terms and similar expressions, as they relate to
us or our management, identify forward-looking statements. Such
statements include, but are not limited to, statements contained in
this press release relating to the view of management of Applied UV
concerning its business strategy, future operating results and
liquidity and capital resources outlook. Forward-looking
statements are based on
the Company's current expectations and assumptions regarding its
business, the economy and other future conditions. Because
forward–looking statements relate to the future, they are subject
to inherent uncertainties, risks and changes in circumstances that
are difficult to predict. The Company's actual results may differ
materially from those contemplated by the forward-looking
statements. They are neither statements
of historical fact nor guarantees of assurance of future
performance. We caution you therefore against relying on any of
these forward-looking statements. Factors or events that could
cause the Company's actual results to differ may emerge from time
to time, and it is not possible for the Company to predict all of
them. The Company cannot guarantee future results, levels of
activity, performance, or achievements. Except as required by
applicable law, including the securities laws of the United States,
the Company does not intend to update any of the forward-looking
statements to conform these statements to actual
results.
For additional Company Information:
Applied UV Inc.
Max Munn
Applied UV Interim CEO
max.munn@sterilumen.com
Contact:
Applied UV Investor Relations
Kevin McGrath
TraDigital IR
+1-646-418-7002
kevin@tradigitalir.com